Exploring the latest research into diabetes

A recent flurry of new studies offers important insights into the treatment and consequences of obesity and diabetes. This issue, IN summarises some highlights from the European Association for the Study of Diabetes (EASD) annual meeting in Madrid during September and recently published peer-reviewed papers.

Semaglutide in renal impairment

According to the charity Kidney Care, about 7.2 million people in the UK live with chronic renal disease and are, therefore, particularly prone to cardiovascular disease. Research presented during the EASD suggests semaglutide is effective at preventing major adverse cardiovascular events (MACE) and all-cause death in people with poor renal function as it is in those with healthy kidneys.